afdx 116 has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davenport, TA; Fukumoto, Y; Gousse, A; Kamai, T; Latifpour, J; Weiss, RM; Yoshida, M | 1 |
| Belmonte, KE; Fryer, AD; Jacoby, DB | 1 |
2 other study(ies) available for afdx 116 and Alloxan Diabetes
| Article | Year |
|---|---|
Diabetes-induced alterations in the properties of muscarinic cholinergic receptors in rat vas deferens.
Topics: Animals; Atropine; Binding, Competitive; Diabetes Mellitus, Experimental; Diamines; Insulin; Male; Parasympatholytics; Piperidines; Pirenzepine; Quinuclidinyl Benzilate; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Up-Regulation; Vas Deferens | 1994 |
Increased function of inhibitory neuronal M2 muscarinic receptors in diabetic rat lungs.
Topics: Acetylcholine; Animals; Bronchoconstriction; Diabetes Mellitus, Experimental; Insulin; Insulin-Like Growth Factor I; Lung; Male; Neural Inhibition; Pilocarpine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptors, Muscarinic; Streptozocin; Vagus Nerve | 1997 |